Physician profile
Christopher Carey
NPI 1770630659
$38,594.55
in general payments reported to CMS, 2019-2025
15 companies · $18K in 2025
The $18K reported for 2025 was more than what 97% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $387 · 2020: $267 · 2021: $1,585 · 2022: $10K · 2023: $1,212 · 2024: $7,124 · 2025: $18K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $20K · Travel and Lodging: $4,154 · Food and Beverage: $1,644.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $20,225.00 |
| Travel and Lodging | $4,153.63 |
| Food and Beverage | $1,644.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $23,278.43 | 2023-2025 | Strattice Reconstructive Tissue Matrix Bps |
| Intuitive Surgical, INC. | $12,347.81 | 2021-2024 | Da Vinci Surgical System |
| Stryker Corporation | $1,594.69 | 2023-2025 | Chromophare F300, 1788, N/A |
| Allergan, INC. | $798.98 | 2019-2022 | |
| Innovation Technologies INC | $118.15 | 2022-2023 | Irrisept |
| Medtronic Vascular, INC. | $113.58 | 2019 | |
| Ethicon US, LLC | $82.62 | 2019-2023 | Enseal |
| Davol INC. | $54.61 | 2021-2023 | |
| Acell, INC. | $39.29 | 2019 | |
| Hologic Sales and Service, LLC | $39.12 | 2023-2024 | Coolseal Generator |
| Medtronic, INC. | $36.10 | 2022 | |
| Collegium Pharmaceutical, INC. | $34.07 | 2022 | |
| Depuy Synthes Sales INC. | $21.72 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $20.98 | 2023 | Andexxa |
| Boston Scientific Corporation | $14.40 | 2025 | Spyglass Discover |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Carey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.